CJC-1295 research guide

CJC-1295 in Petra — GHRH Analog Research Guide

CJC-1295 research guide for Petra. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

CJC-1295 in Petra — Research & Sourcing Guide

Most researchers searching for CJC-1295 in Petra rapidly learn that local retail options are virtually absent. This online-only market structure is actually an advantage for quality — top vendors differentiate through analytical documentation in ways no local retailer can match. What consistently distinguishes top CJC-1295 vendors is complete batch-specific analytical documentation: HPLC for purity, mass spec for identity and weight verification, and endotoxin testing for contamination assurance. Use this guide to assess sourcing options methodically — the quality evaluation approach outlined here are universal across all research contexts.

CJC-1295: What the Research Shows

The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Petra researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.

CJC-1295 Purchasing Guide

Quality CJC-1295 sourcing begins with a straightforward question: does this vendor share complete COA data without being asked? Vendors who do are demonstrating research-grade standards. The HPLC chromatogram is the most important document in the COA: it should show a clear dominant peak representing CJC-1295, with minimal secondary peaks representing impurities — purity should be stated as ≥98%. Warning signs in CJC-1295 vendor evaluation: prices significantly below market average, unclear production details, no community presence, and COAs that lack endotoxin data. For Petra researchers making a first CJC-1295 purchase: work through this evaluation framework first, begin with a small order, and confirm the COA batch number matches your received product before use.

Order CJC-1295 — ships to Petra
COA-verified · International tracking · Research grade
Order Now →

Safe Research Practices for CJC-1295

CJC-1295 operates beyond the scope of approved drug regulation — researchers should understand that the known safety profile is based on research literature rather than clinical trials. Reconstitute CJC-1295 with bacteriostatic water at a concentration matched to your dosing requirements; a standard 5mg in 2mL gives a 2.5mg/mL solution — equivalent to 25mcg per unit on an insulin syringe. Verify the endotoxin level in your CJC-1295 batch COA before any injectable research application — look for results expressed as EU/mg or EU/mL and compare against acceptable research limits for your application. For any individual considering CJC-1295 outside a formal research context: consult a qualified physician — this compound is not approved for human use and its risk profile is not equivalent to approved medications.

Frequently Asked Questions

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →